Document is current
Any future updates will be listed below
-
Authors
Ji, Yun http://orcid.org/0000-0001-6340-7009
Fioravanti, Jessica http://orcid.org/0000-0001-6263-4306
Zhu, Wei
Wang, Hongjun
Wu, Tuoqi
Hu, Jinhui
Lacey, Neal E. http://orcid.org/0000-0002-3633-5924
Gautam, Sanjivan
Le Gall, John B.
Yang, Xia
Hocker, James D.
Escobar, Thelma M.
He, Shan
Dell’Orso, Stefania http://orcid.org/0000-0002-1306-2820
Hawk, Nga V.
Kapoor, Veena
Telford, William G.
Di Croce, Luciano http://orcid.org/0000-0003-3488-6228
Muljo, Stefan A.
Zhang, Yi
Sartorelli, Vittorio
Gattinoni, Luca http://orcid.org/0000-0003-2239-3282
- License Information
-
More Information
Article History
Received: 29 May 2018
Accepted: 2 April 2019
First Online: 14 May 2019
Competing interests
: Y.J. and L.G. are the inventors of an international pending patent on Phf19 technology (“T-CELLS MODIFIED TO OVEREXPRESS PHF19” PCT/US2018/036125 filed on 05 June 2018, applied by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE; Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, Maryland 20892–7660, US). The remaining authors declare no competing interests.
